The life-saving devices will see prices rise by nearly Rs 700 in some cases as the MRP is adjusted for inflation.
NPPA directed all manufacturers and importers of coronary stents whose retail prices are lower than the ceiling set by it to ...
Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
Modesto Bee on MSN17h
Stanislaus County’s top physician says Modesto has good atmosphere for practicing medicineThe Stanislaus Medical Society is recognizing the career of a leading cardiologist in Modesto. Dr. Satnam Ludder is receiving ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Abbott (ABT) announced that the U.S. Food and Drug Administration, FDA, has approved an investigational device exemption, IDE, for its Coronary ...
Abbott begins new Intravascular Lithotripsy trial to improve outcomes in patients with coronary artery disease: Abbott Park, Illinois Wednesday, March 26, 2025, 15:00 Hrs [IST] Ab ...
Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback